Skip to main content
SpringerLink
Log in

Management of Complications Following Minimally Invasive Prostate Cancer Therapy

  • Chapter
  • First Online:
Prostate Cancer: A Comprehensive Perspective

  • 2912 Accesses

Abstract

Minimally invasive techniques such as high-intensity focused ultrasound (HIFU), cryotherapy, and photodynamic therapy are increasingly employed to treat men with both primary and radio-recurrent prostate cancer [1–7]. The use of these technologies is aimed at reducing the well documented toxicity of more traditional prostate cancer treatments, such as radical surgery or radiotherapy, and is hypothesized to result in improved perioperative outcomes and long-term “quality-of-life.” The efficacy of these minimally invasive treatments is discussed in a prior chapter; however, the aim of the current chapter is to review the incidence of complications arising from such therapies and discuss their management. It must be noted however at the outset that there are limited data on the outcome of management strategies employed to treat men experiencing adverse events following minimally invasive prostate cancer treatment [8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL. New treatments for localized prostate cancer. Urology. 2008;72(6 Suppl):S36–43.

    Article  PubMed  Google Scholar 

  2. Inoue Y, Goto K, Hayashi T, Hayashi M. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer. Int J Urol. 2011;18(5):358–62. doi:10.1111/j.1442-2042.2011.02739.x. Epub 2011 Mar 30.

    Article  PubMed  Google Scholar 

  3. Chaussy CG, Thüroff SF. Robotic High-intensity Focused Ultrasound for Prostate Cancer: What Have We Learned in 15 Years of Clinical Use? Curr Urol Rep. 2011;12(3):180–7 [Epub ahead of print].

    Article  PubMed  Google Scholar 

  4. Lian H, Guo H, Gan W, Li X, Yan X, Wang W, Yang R, Qu F. Ji C. Int Urol Nephrol: Cryosurgery as primary treatment for localized prostate cancer; 2011 [Epub ahead of print].

    Google Scholar 

  5. Finley DS. Belldegrun AS. Salvage Cryotherapy for Radiation-Recurrent Prostate Cancer: Outcomes and Complications. Curr Urol Rep; 2011 [Epub ahead of print].

    Google Scholar 

  6. Ahmed HU, Moore C, Emberton M. Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol. 2009;18(3):219–32. Epub 2009 Mar 5. Review.

    Article  PubMed  Google Scholar 

  7. Lepor H. Vascular targeted photodynamic therapy for localized prostate cancer. Rev Urol. 2008;10(4):254–61. Fall.

    PubMed  Google Scholar 

  8. Aus G. Current status of HIFU and cryotherapy in prostate cancer – a review. Eur Urol. 2006;50(5):927–34; discussion 934. Epub 2006 Jul 28.

    Article  PubMed  Google Scholar 

  9. Sherar MD, Trachtenberg J, Davidson SR, McCann C, Yue CK, Haider MA, Gertner MR. Interstitial microwave thermal therapy for prostate cancer. J Endourol. 2003;17(8):617–25. Review.

    Article  PubMed  Google Scholar 

  10. Madersbacher S, Schatzl G, Djavan B, Stulnig T, Marberger M. Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol. 2000;37(6):687–94.

    Article  PubMed  CAS  Google Scholar 

  11. Madersbacher S, Kratzik C, Szabo N, Susani M, Vingers L, Marberger M. Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol. 1993;23 Suppl 1:39–43.

    PubMed  Google Scholar 

  12. Schatzl G, Madersbacher S, Djavan B, Lang T, Marberger M. Two-year results of transurethral resection of the prostate versus four ‘less invasive’ treatment options. Eur Urol. 2000;37(6):695–701.

    Article  PubMed  CAS  Google Scholar 

  13. Ahmed HU, Zacharakis E, Dudderidge T, Armitage JN, Scott R, Calleary J, Illing R, Kirkham A, Freeman A, Ogden C, Allen C, Emberton M. High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series. Br J Cancer. 2009;101(1):19–26. Epub 2009 Jun 9.

    Article  PubMed  CAS  Google Scholar 

  14. Uchida T, Shoji S, Nakano M, Hongo S, Nitta M, Usui Y, Nagata Y. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy. BJU Int. 2011;107(3):378–82.

    Article  PubMed  Google Scholar 

  15. Ritchie RW, Leslie T, Phillips R, Wu F, Illing R, ter Haar G, Protheroe A, Cranston D. Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow-up. BJU Int. 2010;106(7):1004–9.

    Article  PubMed  Google Scholar 

  16. Orsi F, Arnone P, Chen W, Zhang L. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors. J Cancer Res Ther. 2010;6(4):414–20.

    Article  PubMed  Google Scholar 

  17. Hill CR, ter Haar GR. Review article: high intensity focused ultrasound–potential for cancer treatment. Br J Radiol. 1995;68(816):1296–303. Review.

    Article  PubMed  CAS  Google Scholar 

  18. Marberger M. Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation. Curr Opin Urol. 2007;17(3):194–9.

    Article  PubMed  Google Scholar 

  19. Siddiqui K, Chopra R, Vedula S, Sugar L, Haider M, Boyes A, Musquera M, Bronskill M, Klotz L. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. Urology. 2010;76(6):1506–11. Epub 2010 Aug 14.

    Article  PubMed  Google Scholar 

  20. Sesia G, Ferrando U, Riggi G. A new apparatus for use in the cryotherapy of prostate obstruction. Int Surg. 1968;49(4):330–8. No abstract available.

    PubMed  CAS  Google Scholar 

  21. Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. J Endourol. 2007;21(12):1521–31.

    Article  PubMed  Google Scholar 

  22. Shelley M, Wilt TJ, Coles B, Mason MD. Cryotherapy for localised prostate cancer. Cochrane Database Syst Rev. 2007;(3):CD005010.

    Google Scholar 

  23. Davidson SR, Weersink RA, Haider MA, Gertner MR, Bogaards A, Giewercer D, Scherz A, Sherar MD, Elhilali M, Chin JL, Trachtenberg J, Wilson BC. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol. 2009;54(8):2293–313. Epub 2009 Mar 20.

    Article  PubMed  Google Scholar 

  24. Weersink RA, Bogaards A, Gertner M, Davidson SR, Zhang K, Netchev G, Trachtenberg J, Wilson BC. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol B. 2005;79(3):211–22. Epub 2005 Mar 24.

    Article  PubMed  CAS  Google Scholar 

  25. Finley DS, Pouliot F, Miller DC, Belldegrun AS. Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am. 2010;37(1):67–82, Table of Contents. Review.

    Article  PubMed  Google Scholar 

  26. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180(2):559–63; discussion 563–4. Epub 2008 Jun 12.

    Article  PubMed  Google Scholar 

  27. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008;180(2):554–8. Epub 2008 Jun 11.

    Article  PubMed  Google Scholar 

  28. Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007;100(4):760–4. Epub 2007 Jul 23.

    Article  PubMed  Google Scholar 

  29. Ripert T, Azémar MD, Ménard J, Bayoud Y, Messaoudi R, Duval F, Staerman F. Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use. Prostate Cancer Prostatic Dis. 2010;13(2):132–7. Epub 2010 Jan 5.

    Article  PubMed  CAS  Google Scholar 

  30. Koch MO, Gardner T, Cheng L, Fedewa RJ, Seip R, Sanghvi NT. Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer. J Urol. 2007;178(6):2366–70; discussion 2370–1.

    Article  PubMed  Google Scholar 

  31. Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology. 2007;70(6 Suppl):9–15.

    Article  PubMed  Google Scholar 

  32. Robinson JW, Donnelly BJ, Saliken JC, Weber BA, Ernst S, Rewcastle JC. Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology. 2002;60(2 Suppl 1):12–8.

    Article  PubMed  Google Scholar 

  33. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.

    Article  PubMed  Google Scholar 

  34. Braeckman J, Autier P, Garbar C, Marichal MP, Soviany C, Nir R, Nir D, Michielsen D, Bleiberg H, Egevad L, Emberton M. Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int. 2008;101(3):293–8. Epub 2007 Oct 8.

    Article  PubMed  Google Scholar 

  35. Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, Babaian RJ. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997;157(3):921–5.

    Article  PubMed  CAS  Google Scholar 

  36. Wong WS, Chinn DO, Chinn M, Chinn J, Tom WL, Tom WL. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79(5):963–74.

    Article  PubMed  CAS  Google Scholar 

  37. Ahmed S, Davies J. Managing the complications of prostate cryosurgery. BJU Int. 2005;95(4):480–1.

    Article  PubMed  Google Scholar 

  38. Cohen JK, Miller RJ, Rooker GM, Shuman BA. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. Urology. 1996;47(3):395–401.

    Article  PubMed  CAS  Google Scholar 

  39. Uchida T, Shoji S, Nakano M, Hongo S, Nitta M, Murota A, Nagata Y. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Int J Urol. 2009;16(11):881–6.

    Article  PubMed  Google Scholar 

  40. Ahmed HU, Ishaq A, Zacharakis E, Shaw G, Illing R, Allen C, Kirkham A, Emberton M. Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy. BJU Int. 2009;103(3):321–3. Epub 2008 Nov 18.

    Article  PubMed  Google Scholar 

  41. Zacharakis E, Ahmed HU, Ishaq A, Scott R, Illing R, Freeman A, Allen C, Emberton M. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int. 2008;102(7):786–92. Epub 2008 Jun 28.

    Article  PubMed  Google Scholar 

  42. Netsch C, Bach T, Gross E, Gross AJ. Rectourethral Fistula After High-intensity Focused Ultrasound Therapy for Prostate Cancer and Its Surgical Management. Urology. 2011;77(4):999–1004. Epub 2011 Jan 7.

    Article  PubMed  Google Scholar 

  43. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg. 1999;23(2):109–13; discussion 113–4.

    Article  PubMed  CAS  Google Scholar 

  44. El Hayek OR, Alfer Jr W, Reggio E, Pompeo AC, Arap S, Lucon AM, Srougi M. Prostate cryoablation: prospective analysis comparing high- and low-risk prostate cancer outcomes. Urol Int. 2008;81(2):186–90.

    Article  PubMed  Google Scholar 

  45. Cresswell J, Asterling S, Chaudhary M, Sheikh N, Greene D. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int. 2006;97(5):969–74.

    Article  PubMed  Google Scholar 

  46. Anastasiadis AG, Sachdev R, Salomon L, Ghafar MA, Stisser BC, Shabsigh R, Katz AE. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003;129(12):676–82.

    Article  PubMed  Google Scholar 

  47. De La Taille A, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA, Katz AE. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int. 2000;85(3):281–6.

    Article  Google Scholar 

  48. de la Taille A, Hayek O, Benson MC, Bagiella E, Olsson CA, Fatal M, Katz AE. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology. 2000;55(1):79–84.

    Article  PubMed  Google Scholar 

  49. Siddiqui SA, Mynderse LA, Zincke H, Hoffmann NE, Lobo JR, Wilson TM, Kawashima A, Davis BJ, Blute ML. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Urology. 2007;70(1):80–5.

    Article  PubMed  Google Scholar 

  50. Bales GT, Williams MJ, Sinner M, Thisted RA, Chodak GW. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology. 1995;46(5):676–80.

    Article  PubMed  CAS  Google Scholar 

  51. Sumitomo M, Asakuma J, Sato A, Ito K, Nagakura K, Asano T. Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer. Int J Urol. 2010;17(11):924–30.

    Article  PubMed  Google Scholar 

  52. Warmuth M, Johansson T, Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol. 2010;58(6):803–15. Epub 2010 Sep 17.

    Article  PubMed  Google Scholar 

  53. Netsch C, Pfeiffer D, Gross AJ. Development of bladder outlet obstruction after a single treatment of prostate cancer with high-intensity focused ultrasound: experience with 226 patients. J Endourol. 2010;24(9):1399–403.

    Article  PubMed  Google Scholar 

  54. Thüroff S, Chaussy C. High-intensity focused ultrasound: complications and adverse events. Mol Urol. 2000;4(3):183–7. Fall;discussion 189.

    PubMed  Google Scholar 

  55. Berge V, Baco E, Karlsen SJ. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results. Scand J Urol Nephrol. 2010;44(4):223–7.

    Article  PubMed  Google Scholar 

  56. Chalasani V, Martinez CH, Lim D, Chin J. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis. 2009;12(2):124–9. Epub 2008 Oct 14. Review.

    Article  PubMed  CAS  Google Scholar 

  57. Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, Chapelon JY, Gelet A. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol. 2009;55(3):640–7. Epub 2008 May 9.

    Article  PubMed  Google Scholar 

  58. Pasticier G, Chapet O, Badet L, Ardiet JM, Poissonnier L, Murat FJ, Martin X, Gelet A. Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results. Urology. 2008;72(6):1305–9. Epub 2008 May 27.

    Article  PubMed  CAS  Google Scholar 

  59. Gelet A, Chapelon JY, Poissonnier L, Bouvier R, Rouvière O, Curiel L, Janier M, Vallancien G. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology. 2004;63(4):625–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Queen Mary University of London, University College Hospital London and Barts Cancer Institute, Charterhouse Square, London, EC1M 6BQ, UK

    Paul Cathcart M.D., FRCS (Urol)

  2. Department of Urology, Royal Melbourne Hospital, Grattan Street, Parkville 3050, Melbourne, VIC, Australia

    Paul Cathcart M.D., FRCS (Urol)

  3. Department of Urology, Consultant Urological Surgeon, University College Hospital, London, UK

    Paul Cathcart M.D., FRCS (Urol)

  4. Australian Prostate Cancer Research Centre, Epworth Richmond Hospital, Melbourne, VIC, Australia

    Paul Cathcart M.D., FRCS (Urol) & Anthony J. Costello M.D., FRACS

  5. Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

    Paul Cathcart M.D., FRCS (Urol) & Anthony J. Costello M.D., FRACS

  6. St.Barthalomews, Department of Urology, Consultant Urological Surgeon, University College Hospital, London, UK

    Paul Cathcart M.D., FRCS (Urol)

  7. Division of Surgery and Interventional Science, University College London and UCLH/UCL Comprehensive Biomedical Research Centre, London, UK

    Paul Cathcart M.D., FRCS (Urol)

  8. Department of Urology, Royal Melbourne Hospital, 32 Erin Street, Richmond, Melbourne, VIC, Australia

    Anthony J. Costello M.D., FRACS

Authors
  1. Paul Cathcart M.D., FRCS (Urol)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony J. Costello M.D., FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Cathcart M.D., FRCS (Urol) .

Editor information

Editors and Affiliations

  1. New York Presbyterian Hospital, Brady Urologic Health Center, Weill Cornell Medical Center, East 68th Street 525, New York, 10021, New York, USA

    Ashutosh Tewari

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Cathcart, P., Costello, A.J. (2013). Management of Complications Following Minimally Invasive Prostate Cancer Therapy. In: Tewari, A. (eds) Prostate Cancer: A Comprehensive Perspective. Springer, London. https://doi.org/10.1007/978-1-4471-2864-9_85

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2864-9_85

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2863-2

  • Online ISBN: 978-1-4471-2864-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation